Finding suitable targets is the major obstacle to cancer gene therapy.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 2, p. 45, doi. 10.1038/cgt.2014.3
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2014 AND VI 21 AND IP 2
Results: 7
1
2
The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 2, p. 68, doi. 10.1038/cgt.2013.85
- By:
- Publication type:
- Article
3
Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 2, p. 48, doi. 10.1038/cgt.2013.84
- By:
- Publication type:
- Article
4
Abscopal effect of low-LET γ-radiation mediated through Rel protein signal transduction in a mouse model of nontargeted radiation response.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 2, p. 54, doi. 10.1038/cgt.2013.72
- By:
- Publication type:
- Article
5
Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 2, p. 60, doi. 10.1038/cgt.2013.82
- By:
- Publication type:
- Article
6
Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 2, p. 74, doi. 10.1038/cgt.2013.86
- By:
- Publication type:
- Article
7
Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 2, p. 83, doi. 10.1038/cgt.2013.87
- By:
- Publication type:
- Article